Increased prevalence of obesity and obesity-related postoperative complications in male patients with meningiomas

Neurosurgery

Volumn 61, Issue 4, 2007, Pages 754-760

  Aghi, Manish K ^a,b   Eskandar, Emad N ^a,b   Carter, Bob S ^a,b   Curry, William T ^a,b   Barker, Fred G ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Estrogen; Male; Meningioma; Obesity; Postoperative complications

Indexed keywords

STEROID HORMONE;

ADULT; ANEURYSM; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOTOMY; DEEP VEIN THROMBOSIS; FEVER; GLIOBLASTOMA; GLIOMA; HORMONE SYNTHESIS; HUMAN; LIQUORRHEA; LUNG EMBOLISM; MALE; MENINGIOMA; OBESITY; POSTOPERATIVE COMPLICATION; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEIZURE; STROKE; THROMBOPHLEBITIS;

BODY MASS INDEX; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; OBESITY; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 35948983745     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000298903.63635.E3     Document Type: Article

References (39)

1. Adly L, Hill D, Sherman ME, Sturgeon SR, Fears T, Mies C, Ziegler RG, Hoover RN, Schairer C: Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal women. Int J Cancer 119:2402-2407, 2006.
2. Bamia C, Trichopoulou A, Lenas D, Trichopoulos D: Tobacco smoking in relation to body fat mass and distribution in a general population sample. Int J Obes Relat Metab Disord 28:1091-1096, 2004.
3. Bellur SN, Chandra V, Anderson RJ: Association of meningiomas with obesity. Ann Neurol 13:346-347, 1983.
4. Bondy M, Ligon BL: Epidemiology and etiology of intracranial meningiomas: A review. J Neurooncol 29:197-205, 1996.
5. Carmichael AR: Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 113:1160-1166, 2006.
6. Centers for Disease Control and Prevention: Health risks in the United States: Behavioral Risk Factor Surveillance System. Hyattsville, U.S. Department of Health and Human Services, 2005.
7. Cleland WH, Mendelson CR, Simpson ER: Aromatase activity of membrane fractions of human adipose tissue stromal cells and adipocytes. Endocrinology 113:2155-2160, 1983.
8. Costa-Bouzas J, Takkouche B, Cadarso-Suárez C, Spiegelman D: HEpiMA: Software for the identification of heterogeneity in meta-analysis. Comput Methods Programs Biomed 64:101-107, 2001.
9. Grantmakers in Health: Weighing in on obesity: America's growing health epidemic. Washington, D.C., Grantmakers in Health, 2001, p 11.
10. Grosse H: Coincidence of liver cirrhosis, diabetes mellitus, hypertension, obesity, cholecystopathy and meningioma in elderly women [in German]. Zentralbl Allg Pathol 125:410-413, 1981.
11. Helseth A, Tretli S: Pre-morbid height and weight as risk factors for development of central nervous system neoplasms. Neuroepidemiology 8:277-282, 1989.
12. Jacobs DH, McFarlane MJ, Holmes FF: Meningiomas and obesity reconsidered. Ann Neurol 20:376, 1986.
13. Jhawar BS, Fuchs CS, Colditz GA, Stampfer MJ: Sex steroid hormone exposures and risk for meningioma. J Neurosurg 99:848-853, 2003.
14. Kanaan I, Jallu A, Kanaan H: Management strategy for meningioma in pregnancy: A clinical study. Skull Base 13:197-203, 2003.
15. Kurihara M, Tokunaga Y, Tsutsumi K, Kawaguchi T, Shigematsu K, Niwa M, Mori K: Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma. J Neurosurg 71:538-544, 1989.
16. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F: Association of meningioma with reproductive factors. Int J Cancer 119:1152-1157, 2006.
17. Longstreth WT Jr, Dennis LK, McGuire VM, Drangsholt MT, Koepsell TD: Epidemiology of intracranial meningioma. Cancer 72:639-648, 1993.
18. Matsuno A, Fujimaki T, Sasaki T, Nagashima T, Ide T, Asai A, Matsuura R, Utsunomiya H, Kirino T: Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504-510, 1996.
19. McCourt CK, Mutch DG, Gibb RK, Rader JS, Goodfellow PJ, Trinkaus K, Powell MA: Body mass index: Relationship to clinical, pathologic and features of microsatellite instability in endometrial cancer. Gynecol Oncol 104:535-539, 2007.
20. Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, Marks JS: Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289:76-79, 2003.
21. Mujahid MS, Diez Roux AV, Borrell LN, Nieto FJ: Cross-sectional and longitudinal associations of BMI with socioeconomic characteristics. Obes Res 13:1412-1421, 2005.
22. NHLBI Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Obesity Res 6 [Suppl 2]: 51S-209S, 1998.
23. Ohta M, Iwaki T, Kitamoto T, Takeshita I, Tateishi J, Fukui M: MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management. Cancer 74:3176-3189, 1994.
24. Olson S, Law A: Meningiomas and the Polynesian population. ANZ J Surg 75:705-709, 2005.
25. Omulecka A, Papierz W, Nawrocka-Kunecka A, Lewy-Trenda I: Immunohistochemical expression of progesterone and estrogen receptors in meningiomas. Folia Neuropathol 44:111-115, 2006.
26. Pischon T, Lahmann PH, Boeing H, Friedenreich C, Norat T, Tjonneland A, Halkjaer J, Overvad K, Clavel-Chapelon F, Boutron-Ruault MC, Guernec G, Bergmann MM, Linseisen J, Becker N, Trichopoulou A, Trichopoulos D, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, Bueno-de-Mesquita HB, Boshuizen HC, Van Guelpen B, Palmqvist R, Berglund G, Gonzalez CA, Dorronsoro M, Barricarte A, Navarro C, Martinez C, Quirós JR, Roddam A, Allen N, Bingham S, Khaw KT, Ferrari P, Kaaks R, Slimani N, Riboli E: Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 98:920-931, 2006.
27. Preston-Martin S, Monroe K, Lee PJ, Bernstein L, Kelsey J, Henderson S, Forrester D, Henderson B: Spinal meningiomas in women in Los Angeles County: Investigation of an etiological hypothesis. Cancer Epidemiol Biomarkers Prev 4:333-339, 1995.
28. Rodriguez C, Freedland SJ, Deka A, Jacobs EJ, McCullough ML, Patel AV, Thun MJ, Calle EE: Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16:63-69, 2007.
29. Schneider B, Pülhorn H, Röhrig B, Rainov NG: Predisposing conditions and risk factors for development of symptomatic meningioma in adults. Cancer Detect Prev 29:440-447, 2005.
30. Speirs V, Boyle-Walsh E, Fraser WD: Constitutive co-expression of estrogen and progesterone receptor mRNA in human meningiomas by RT-PCR and response of in vitro cell cultures to steroid hormones. Int J Cancer 72:714-719, 1997.
31. Spiegelman D, Israel RG, Bouchard C, Willett WC: Absolute fat mass, percent body fat, and body-fat distribution: Which is the real determinant of blood pressure and serum glucose? Am J Clin Nutr 55:1033-1044, 1992.
32. U.S. Census Bureau. American Fact Finder. 2000. http://factfinder.census. gov/servlet/DTGeoSearchByListServlet?ds_name=DEC_2000_SF3_U&_langen&_ts= 191290337368. Accessed March 7, 2007.
33. Verkasalo PK, Thomas HV, Appleby PN, Davey GK, Key TJ: Circulating levels of sex hormones and their relation to risk factors for breast cancer: A cross-sectional study in 1092 pre- and postmenopausal women (United Kingdom). Cancer Causes Control 12:47-59, 2001.
34. Vermeulen A, Kaufman JM, Goemaere S, van Pottelberg I: Estradiol in elderly men. Aging Male 5:98-102, 2002.
35. Weiss JR, Moysich KB, Swede H: Epidemiology of male breast cancer. Cancer Epidemiol Biomarkers Prev 14:20-26, 2005.
36. Wigfield CH, Lindsey JD, Muñoz A, Chopra PS, Edwards NM, Love RB: Is extreme obesity a risk factor for cardiac surgery? An analysis of patients with a BMI > or = 40. Eur J Cardiothorac Surg 29:434-440, 2006.
37. Wyatt SB, Winters KP, Dubbert PM: Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem. Am J Med Sci 331:166-174, 2006.
38. Yu ZY, Wrange O, Haglund B, Granholm L, Gustafsson JA: Estrogen and progestin receptors in intracranial meningiomas. J Steroid Biochem 16:451-456, 1982.
39. Zumoff B, Miller LK, Strain GW: Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone. Metabolism 52:1126-1128, 2003.